RhumbLine Advisers’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,386
| Closed | -$4.33K | – | 4262 |
|
|
2024
Q2 | $4.33K | Sell |
3,386
-17,546
| -84% | -$22.5K | ﹤0.01% | 4106 |
|
|
2024
Q1 | $60.5K | Buy |
20,932
+909
| +5% | +$2.63K | ﹤0.01% | 3584 |
|
|
2023
Q4 | $147K | Buy |
20,023
+217
| +1% | +$1.6K | ﹤0.01% | 3321 |
|
|
2023
Q3 | $152K | Buy |
19,806
+2,275
| +13% | +$17.5K | ﹤0.01% | 3302 |
|
|
2023
Q2 | $178K | Buy |
+17,531
| New | +$178K | ﹤0.01% | 3297 |
|
|
2022
Q2 | – | Sell |
-13,819
| Closed | -$89K | – | 3164 |
|
|
2022
Q1 | $89K | Buy |
+13,819
| New | +$89K | ﹤0.01% | 2907 |
|